Baird Medical Investment Holdings Limited (BDMD) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Baird Medical Investment Holdings Limited (BDMD) Earnings Overview
As of June 28, 2026, Baird Medical Investment Holdings Limited (BDMD) reported trailing twelve-month net income of -$15M, reflecting -300.0% year-over-year growth. The company earned $-0.51 per diluted share over the past four quarters, with a net profit margin of -121.0%.
Looking at the long-term picture, BDMD's historical earnings data spans multiple years. The company achieved its highest annual net income of $13M in fiscal 2022.
Baird Medical Investment Holdings Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), ARAY (-$46M net income, -0.3% margin), AEYE (-$4M net income, -7.6% margin), BDMD has room to improve margins relative to the peer group. Compare BDMD vs NVCR →
BDMD Earnings vs Peers
Earnings metrics vs comparable public companies
BDMD Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$27M | -319.0% | -$26M | $-0.98 | -121.0% | -113.3% |
| 2024 | $12M | +18.1% | $15M | $0.49 | 33.6% | 41.4% |
| 2023 | $11M | -16.1% | $12M | $0.41 | 33.5% | 37.7% |
| 2022 | $13M | +7.6% | $14M | $0.02 | 35.8% | 38.8% |
| 2021 | $12M | +64.5% | $12M | $-0.02 | 42.1% | 43.0% |
| 2020 | $7M | +198.8% | $10M | $0.99 | 39.2% | 54.4% |
| 2019 | -$7M | - | $6M | $-1.00 | -58.8% | 45.9% |
Download Data
Export BDMD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BDMD — Frequently Asked Questions
Quick answers to the most common questions about buying BDMD stock.
What is BDMD earnings per share (EPS)?
BDMD trailing twelve-month (TTM) diluted EPS is $-0.51, reflecting -300.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Baird Medical Investment Holdings Limited's net income?
Baird Medical Investment Holdings Limited (BDMD) trailing twelve-month net income is $-15M as of 2025. Earnings declined -300.0% year-over-year.
Is BDMD profitable?
BDMD is not currently profitable on a TTM basis, reporting a net loss of $-15M. Net margin is -121.0%. Investors should monitor for a return to profitability.
What is BDMD's earnings growth rate?
BDMD compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are BDMD's profit margins?
Baird Medical Investment Holdings Limited net profit margin is -121.0%, operating margin is -113.3%, and gross margin is +83.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is -76.9%.
Is BDMD growing earnings?
BDMD earnings are declining — EPS fell -300.0% year-over-year. TTM net income dropped to $-15M. This contrasts with the 5-year CAGR of N/A.
What was BDMD's best earnings year?
Baird Medical Investment Holdings Limited's highest annual net income on record is $13M, achieved in fiscal year 2022. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were BDMD's earnings last quarter?
BDMD's most recent reported quarter was Q4 2025. Net income was $-16M with diluted EPS of $-0.55. For a full breakdown of all quarters, see the quarterly earnings table on this page.